Periodontitis and Cardiovascular Events or "PAVE"
Periodontal Intervention for Cardiac Events: A Pilot Trial
2 other identifiers
interventional
303
1 country
1
Brief Summary
The purpose of this study is to determine if treating periodontal infections (gum problems) will lead to fewer heart problems in patients at high risk for cardiovascular disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2003
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2003
CompletedFirst Submitted
Initial submission to the registry
August 1, 2003
CompletedFirst Posted
Study publicly available on registry
August 5, 2003
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2005
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2005
CompletedAugust 5, 2011
May 1, 2007
2.4 years
August 1, 2003
August 4, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Patient outcomes are hospitalized for myocardial infarction (MI), cardiac revascularization, fatal coronary heart disease, unstable angina, and/or hospitalized ischemic stroke.
One year
Study Arms (2)
Periodontal Treatment: SRP
EXPERIMENTALComprehensive scaling \& root planing and subgingival tissue removal; fluorides applied as appropriate; oral hygiene instructions.
Community Comparator
ACTIVE COMPARATORReferral to community dentist with copy of x-rays and letter with diagnosis and recomendations for treatment.
Interventions
Scaling and root planing. Subgingival tissue removal. Fluorides as needed. Oral hygiene instructions. Oral hygiene instructions.
Eligibility Criteria
You may not qualify if:
- Any of the following:
- A major illness requiring hospitalization,
- Renal dialysis,
- Serum creatinine \> 3 mg/dl,
- Organ transplant recipient requiring immunosuppression medication,
- Surgery needed in the next 3 years,
- Chemotherapy in the past 3 years,
- Head and/or neck radiation at any time in the past,
- Liver dysfunction,
- Class IV congestive heart failure,
- Drug or alcohol abuse,
- Pacemaker or AICD/defibrillator.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University at Buffalo
Buffalo, New York, 14214, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sara G Grossi, DDS, MS
University at Buffalo
- PRINCIPAL INVESTIGATOR
Thomas E van Dyke, DDS,MS
Goldman School of Dental Medicine, Boston, MA
- PRINCIPAL INVESTIGATOR
John C Gunsolley, DDS,MS
University of Maryland, Dept. of Periodontics, Baltimore, MD
- PRINCIPAL INVESTIGATOR
James D Beck, Ph.D
University of NC, School of Dentistry, Chapel Hill, NC
- PRINCIPAL INVESTIGATOR
Lloyd E Chambless, PhD,
University of NC, Dept. of Biostatistics, Chapel Hill, NC
- PRINCIPAL INVESTIGATOR
Steven Offenbacher, DDS,PhD,MMSc
University of NC, Comprehensive Cntr. for Inflammatory Diseases, Chapel Hill, NC
- PRINCIPAL INVESTIGATOR
Theresa Madden, DDS, PhD
Oregon Health and Science University, Portland, OR
- PRINCIPAL INVESTIGATOR
Gerardo Maupome, PhD
Kaiser-Permanente Center for Health Research, Portland, OR
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
August 1, 2003
First Posted
August 5, 2003
Study Start
January 1, 2003
Primary Completion
June 1, 2005
Study Completion
June 1, 2005
Last Updated
August 5, 2011
Record last verified: 2007-05